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Although the lymph node lymphatic vessel growth and development is positively regulated by B cells and
macrophages, Kataru et al. (2011), in this issue of Immunity, show negative regulation of lymphatic vessels
by interferon-g from T cells.Lymph nodes (LNs) can act as immuno-
logical filters that are strategically situated
throughout the mammalian body to trap
particles or antigens from peripheral
tissue. LNs maintain active homeostasis
in size and content at steady state.
However, their size changes dramatically
in response to changes in the local envi-
ronment such as infection, cancer, and
vaccination. These conditions lead to
enlarged LNs followed by regression after
the resolution of inflammation. Remodel-
ing of lymphatic vessels (LVs) and blood
vessels (BV) are thought to be a key step
in controlling these changes. Which cells,
membrane or soluble cytokines, are es-
sential for lymphatic vessel homeostasis
and dynamic changes in expansion and
regression phases have not been well
defined. Recent studies have reported
that peripheral inflammation transiently
induces robust lymphangiogenesis in
draining LNs (Halin et al., 2007; Kataru
et al., 2009; Liao and Ruddle, 2006).
Vascular endothelial growth factors
(VEGFs) are thought to mediate most of
this LN lymphangiogenesis, and VEGF-
A, -C, and -D are increased at the site of
inflammation (Halin et al., 2007; Kataru
et al., 2009). Various intranodal cellular
components, such as B cells, stromal
fibroblastic reticular cells, and macro-
phages, are also involved in the process
of inflammatory LN lymphangiogenesis
by secreting VEGFs (Angeli et al., 2006;
Chyou et al., 2008; Kim et al., 2009).
Rapidly moving T cells encounter their
specific antigen inside draining LNs via
LNLVs to initiate adaptive immune res-
ponses. Although T cells are one of the
major cellular components and effector
cells in the LN, their role in LN homeo-
stasis or inflammatory remodeling has
not been fully understood. A previous
study found no role of T cells on LN8 Immunity 34, January 28, 2011 ª2011 Elsevenlargement or DC migration (Angeli
et al., 2006). Intriguingly, Kataru et al.
(2011), in this issue of Immunity, reveal
a role for T cell-mediated negative regula-
tion of LVs.
Kataru et al. (2011) first characterized
LNLVs in athymic mice at steady state
and found increased LNLVs as compared
to euthymic mice, suggesting an inhibi-
tory effect of T cells on LNLV homeo-
stasis. However, this observation does
not necessarily rule out other possibilities
such as an unknown developmental
defect in athymic mice or compensatory
function of innate cells or B cells. Indeed,
higher percentage of macrophages and
dendritic cells were found in LNs of athy-
mic mice. To address these concerns,
T cells were depleted from naive wild-
type (WT) mice via anti-CD3. As pre-
dicted, depletion of T cells markedly
increased LNLV density. Interestingly,
LNLVs regressed after T cells were
restored. The gain-of-function experiment
by adoptive transfer also demonstrated
that either CD4+ or CD8+ T cells, but not
B cells, were able to suppress LNLVs in
athymic mice, indicating a direct impact
of T cells on the LNs. The inhibitory impact
of T cells is more prominent when they are
activated. Thus, factors from activated
T cells were speculated to suppress
LNLV growth.
Interferon-g (IFN-g) is well known for its
antiangiogenic effect (Ruegg et al., 1998).
Kataru et al. (2011) hypothesized that
T cell-derived IFN-g is the LNLV-inhibitory
factor. Indeed, IFN-g treatment markedly
reduced LNLV density. Furthermore,
adoptive transfer of T cells from IFN-g-
deficient mice could not suppress the
increased LNLV density in athymic mice.
However, it is noteworthy that LNLV
suppression still occurred in areas where
IFN-g-deficient T cells were heavily popu-ier Inc.lated. These results together suggest that
IFN-g from T cells is a potent factor for
LNLV suppression, but whether this is
a direct or indirect role on the lymphatic
vessels is less clear. Because very few
T cells in the LNs of naive WT mice
produce IFN-g, it is intriguing that so few
IFN-g-producing T cells would have
such a profound effect on LNLV suppres-
sion. Therefore, the T cell density and
proximity to LNLV might be important.
Kataru et al. (2011) further tested the
role of T cell-derived IFN-g in an inflam-
mation model induced by intradermal
injection of LPS. WT and IFN-g-deficient
mice show similar LNLV increase at the
expansion stage of LN upon LPS stimu-
lation. During the resolving stage,
although LNLVs markedly regressed in
WT mice, the amount of LNLVs in IFN-
g-deficient mice remained elevated. To
further rule out any possible indirect
role of IFN-g through innate cells or B
cells, which are important for LN lym-
phangiogenesis, bone marrow transplan-
tation and double adoptive transfer
experiments were performed. IFN-g
receptor 1 expression on radioresistant
cells (including LNLV endothelial cells)
but not bone marrow-derived cells
(including macrophages, DCs, and B
cells) was required for LNLV regression
at the resolving stage of LPS stimulation.
Although these results support a direct
role of T cell-derived IFN-g on LNLV
inhibition, it is still unclear whether
stromal fibroblastic reticular cells and
their VEGF production are involved
(Chyou et al., 2008). Conditional deletion
of IFN-g receptor in the various cells
would help to distinguish whether LNLV
or fibroblastic reticular cells is the target.
The authors further designed a series
of in vitro experiments demonstrating
a direct inhibition of IFN-g on LNLV
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Figure 1. Dynamic Regulation of Lymphatic Vessels by Distinct Immune Cells
Upon local stimulation by pathogen-associated molecular patterns such as lipopolysaccharide or CpG
DNA, B cells and innate cells such as macrophages are activated and secrete VEGF, which promotes
lymphangiogenesis. We speculate that B cells also deliver lymphotoxin signaling to fibroblastic reticular
cells for additional VEGF production. At a later stage of inflammation, differentiated Th1 cells and CTLs
inhibit lymphatic endothelial cell growth through IFN-g, leading to LV regression. Some unknown mech-
anisms may also negatively regulate VEGF production from B cells and FRCs. It is unclear whether other
subsets of Th cells or other types of cells play any role for LV regression.
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Previewsendothelial cell (LEC) growth. Prox-1, the
master transcriptional factor of LECs,
was markedly but not completely in-
hibited by T cell-derived IFN-g on pri-
mary cultured LECs in vitro through
the JAK1-STAT1 signaling pathway. This
result suggests the presence of other
T cell-derived factors on LNLV negative
regulation.
What is the biological significance and
implications of this work? LNLVs are
used as conduits to facilitate the physical
interaction between antigen-carrying DCs
and their corresponding T cells (von An-
drian and Mempel, 2003). An intriguing
result of this study is that the elevated
LV density in T cell-deficient instead of B
cell-deficient LNs is associated with the
increased recruitment of antigen-carrying
DCs into the LNs. The biological function
of LNLV regression for immune cell
retention or exit is currently unknown.
This IFN-g-mediated LNLV suppression
might also help to prevent excessive
immune responses, which might be im-
munopathogenic, leading to autoimmu-
nity or inhibiting memory T cell genera-
tion. In addition, are T cells and IFN-g
unique in this setting? NK cells migrateinto LNs during early inflammation and
they also produce IFN-g (Martin-Fonte-
cha et al., 2004). Could NK cell-derived
IFN-g also induce LNLV regression even
before T cells? Although other sources
of IFN-g in the LNs are present early in
the response, it could be that the LNLV
does not regress because the corre-
sponding positive signals that increase
LN size are dominant at the initiation
phase of the immune response. At late
stages, however, the positive signals
may subside, allowing for negative regu-
lation of the LNLV by antigen-expended
T cells to be dominant.
IFN-g production from antigen-reactive
T cells might indicate a well-developed
T helper 1 (Th1) cell response, which is
important for viral clearance, but too
much IFN-g could be detrimental to the
body. From an evolutionary point of
view, the host wants an optimal amount
of IFN-g in response to antigens or
inflammation. If, for example, T cells are
disregulated and produce too much
IFN-g, this negative-feedback mecha-
nism controlling LNLV regression could
be initiated to control the extent of inflam-
mation- and/or antigen-specific immuneImmunityresponses. The current study reveals
a role of T cell-derived IFN-g on LNLV
inhibition and raises many interesting
questions. In addition to IFN-g, can other
cytokines play a similar role? Do IL4,
IL-17, and IL-22 from other subset of
T cells have similar function on LNLV?
Does this effect on LNLV also apply to
LN high endothelial venule (HEV) cells
as well? Because HEV is the critical
site where T cells migrate into LN,
a negative-feedback mechanism on HEV
itself would be more efficient. In addition,
can effector Th1 cells control peripheral
tissue vessels during their effector
phase? This would be also helpful for
the resolution of peripheral tissue
inflammation.
LN homeostasis and remodeling is
a dynamic progress involving different
cellular components at various times and
locations and host environmental condi-
tions. Although B cells and some innate
cells are critical for LN remodeling at the
early stage of inflammation, T cells have
now been found to be a critical negative-
feedback regulator at the resolving stage
(Figure 1). It is intriguing how this kinetic
regulation occurs. One can speculate
that B cells and innate cells can be acti-
vated in a nonantigen-specific way by
danger signals and thus respond earlier
during inflammation to produce VEGF.
In addition, B cell-derived lymphotoxin
could stimulate stroma fibroblastic
reticular cells for additional VEGF pro-
duction. As for T cells, they have to
undergo antigen-specific activation and
differentiation for enough IFN-g produc-
tion, which takes longer time and thus its
function may display later. Perhaps an
unknown negative regulation mechanism
on VEGF production also exists to allow
T cell-derived IFN-g to dominate at the
later stage of inflammation. Kataru et al.
(2011) have extended our understanding
about this process and raised a series of
stimulating questions to be addressed in
the future.REFERENCES
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Expression of the chemokine receptor CXCR5 identifies B follicular helper T cells. In this issue of Immunity,
Morita et al. (2011) describe a heterogeneous circulating CXCR5+CD4+ B cell helper population overrepre-
sented in juvenile dermatomyositis patients.Central memory (Tcm) and naive T cells
populate T zones of secondary lymphoid
organs, by virtue of expression of the che-
mokine receptor CCR7, L-selectin, and
the integrin LFA-1. Tcm cells express IL-
2 but are not necessarily polarized to T
helper (Th) cell phenotypes. By contrast,
effector memory T (Tem) cells are mostly
polarized (Th1, Th2, and Th17 cells),
secrete cytokines abundantly, have lost
CCR7, and express receptors for chemo-
kines upregulated in inflamed nonimmune
parenchyma. In the past decade, B follic-
ular helper T cells (Tfh cells) have been
characterized as another type of CD4+
helper T cell that specifically differentiate
under the influence of the transcription
factor Bcl-6.
Tfh cells exhibit effector function (help
for B cells), and like other T effectors,
have downregulated CCR7. Despite this,
they are disproportionately located in
secondary lymphoid organs rather than
inflamed nonlymphoid parenchyma, but
specifically within follicles rather than
T zones (Campbell et al., 2003). This is
due to loss of CCR7 and expression of
CXCR5, the receptor for CXCL13, which
is expressed constitutively by follicular
stroma. CXCR5 is expressed by all
mature B cells and by a small proportion
of memory T cells, but the highest expres-sion of CXCR5 is found on Tfh cells. Tfh
cells secrete predominantly IL-21 and
IL-4 and lesser amounts of IFN-g and
IL-17 (Yu and Vinuesa, 2010). To compli-
cate matters further, there appears to be
another population of T cells that is
dependent on Bcl6, exhibits Tfh cell-like
activity, but is located in extrafollicular
plasma cell foci (Poholek et al., 2010). In
this issue of Immunity, Morita et al.
(2011) identify a subset of circulating
CXCR5+ T cells with potent B cell helper
activity.
The ontogeny of Tfh cells remains
unknown. It is not clear whether they
differentiate from T cells shortly after
priming, or whether early Th1, Th2, and/or
Th17 cells can adopt follicular differentia-
tion upon exposure to cytokines such as
IL-6 and IL-21 in mice and IL-12 in
humans. Their relation to CXCR5+ T cells
in blood also remains uncertain. These
cells are absent from the blood in patients
lacking ICOS, which suggests that they
are related to Tfh cells (Bossaller et al.,
2006). This is also supported by their
abundance in mouse models character-
ized by excessive Tfh cell production in
secondary lymphoid tissues (Simpson
et al., 2010). It is possible that T cells
with intermediate expression of CXCR5,
shown to be potent IFN-g and IL-17producers (Yu and Vinuesa, 2010), could
be precursors of GC Tfh cells (Figure 1).
Earlier work showed that in humans,
CXCR5+ cells appear in the blood shortly
after immunization, and CXCR5 is
induced rapidly by naive and CD27+
memory cells (but not CD27 Tem cells)
(Schaerli et al., 2001). Compared with
their tonsillar counterparts, circulating
CXCR5+ T cells appeared to offer little
support for antibody production in cocul-
ture with autologous B cells in the
absence of exogenous antigen (Schaerli
et al., 2000).
Now, Morita et al. (2011) report that
CXCR5+ T cells from human peripheral
blood provide better help to B cells than
their CXCR5 counterparts. Circulating
CXCR5+ T cells are shown to be more
effective in providing help to naive B cells
at least in the presence of the superanti-
gen staphylococcal enterotoxin B (SEB)
(Morita et al., 2011). In coculture, B cells
differentiate into plasmablasts and
produced Ig within 6 days, in an
IL-21- and ICOS-dependent manner. By
contrast, CXCR5 populations are unable
to induce any switched Ig and only small
amounts of IgM. Furthermore, consistent
with previous findings (Schaerli et al.,
2001), the CXCR5+ cells sampled from
patients not recently vaccinated made
